Author – Mandi Axmann
Four medical doctors in a virtual room adjust their light and sound settings. ‘Let’s just wait for some more people to hop on, and then we can begin our meeting.’ They have set up a webinar to discuss the application of triple therapy Ivermectin, Doxycycline and Zinc as both preventative agent and treatment for SARS-C0V-2 (COVID-19).
A recent outbreak in South Africa has seen infections increase to 5,000 people testing positive in a 24-hour period. Dr George Coetzee2, a medical practitioner in Pretoria, stated that he is currently seeing 20-30 COVID patients a day, and yet none of those patients that he has treated within the first two weeks of infection has died or ended up in ICU, due to his treatment protocol.
Dr Coetzee explains that the disease has two phases, namely an early phase where high levels of the the virus is present, and the viral load triggers an immune response. Antiviral drugs such as Ivermectin may inhibit virus transmission and destroy virus replication can reduce direct cell damage, and appropriate combinations with immunoregulatory therapies that inhibit hyper-activated inflammatory responses can resist cytokine storms3 triggered by the virus in the latter phase.
Almost more than a year ago (August 9, 2020) Sky News conducted an interview with gastroenterologist Professor Thomas Borody4, who said the Australian government should allow the clinical trials of a drug he says is ‘amazingly effective’ in treating the deadly coronavirus COVID-19. Prof Borody is of the opinion that Ivermectin can be used both as a preventative agent and a cure, keeping in mind that vaccines does not cure a disease.
A follow-up interview with Melbourne GP Dr Mark Hobart confirmed that it is ‘..worth giving Ivermectin triple therapy as a treatment for COVID-19 patients because it is harmless medication, it has shown a great deal of promise, and otherwise patients will receive no treatment.’
A recent systematic review and meta-analysis of global research studies was performed by Dr Tess Lawrie and an international research team. She concluded that it is very apparent from her comprehensive research that Ivermectin has both anti-viral and anti-inflammatory properties, and is a very safe and effective treatment.
With all this information widely and freely available, why is the Australian government hush on the topic? A medication that shows to prevent death world-wide by 63% as a conservative estimate, should by now have perked the interest of the medical community, or at the very least gained sufficient momentum to run a trial for infected patients within Australia.
Currently, the Australian Government Department of Health7 states that there is ‘..insufficient evidence to support the safe and effective use of ivermectin, doxycycline and zinc (either separately, or in combination) for the prevention or treatment of COVID-19. More robust, well-designed clinical trials are needed before they could be considered an appropriate treatment option’ (cited 18 June 2021).
If this is the health advice, should Australia not be participating in the global research arena or conducting such trials?
1 Dr John Campbell interviews Dr Tess Lawrie (Apr 7, 2021) Discussion on global comparative study of Ivermectin.
2 Maroela Media (June,4 2021) This is what you need to know about Ivermectin and Covid
3 Tang, L. Yin, Z. Hu, Y. and Mei, H. (2020) Controlling Cytokine Storm is vital in Covid-19. Front Immunol, 30 Nov 2020, https://doi.org/10.3389/fimmu.2020.570993
4 Sky News (September, 8 2020) Melbourne GP says Ivermectin treatment is ‘very effective’.
5 Sky News (August, 9 2020) Interview with Gastrointerologist Prof Thomas Borody
6 Behera, P. et al (Feb 2021) Role of Ivermectin in the prevention of SARS-Cov-2 infection among healthcare workers in India: A matched case-control study. PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247163